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Introduction
Mycobacterium tuberculosis is regarded as one of the most suc-
cessful human pathogens. It is responsible for more deaths than 
any other microorganism, and moreover, one third of the global 
population is showing immunological evidence of past or current 
infection. This occurs predominantly in the form an asymptom-
atic “latent” infection, resembling carriage of a commensal organ-
ism, and only a minority of individuals develop the progressive 
lung disease that is necessary for maintenance of the transmission 
cycle. In contrast to well-characterized enteric pathogens that 
rely on the acquisition and expression of specialized “virulence 
factors,” pathogenesis of M. tuberculosis depends on an ability 
to adjust to changing environments within the host and, under 
appropriate circumstance, to transmit signals that subvert the 
immune response in order to cause localized immunopathology.1
Efforts to understand the molecular basis of mycobacterial 
pathogenesis, with the aim of identifying interventions that 
prevent or resolve disease, focus on understanding of the ability 
of the bacteria to modulate their metabolism and replication in 
response to different environmental signals. The 4.4 megabase 
genome of M. tuberculosis encodes 13 sigma factors and more 
than 100 annotated transcriptional regulators,2 and an extensive 
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It is estimated that one third of the human population is 
infected with Mycobacterium tuberculosis. Efforts to understand 
the molecular basis of its gene regulation have been focused 
on identification of protein encoding genes and regulons 
implicated in pathogenesis. Recently, a number of studies have 
described the identification of several non-coding RNAs that 
are likely to contribute significantly to the regulatory networks 
responsible for adaptation and virulence in M. tuberculosis. 
We have reviewed emerging information on the presence 
and abundance of different types of non-coding RNA in M. 
tuberculosis and consider their potential contribution to the 
adaptive responses that underlie disease pathogenesis.
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literature documents transcriptional changes in response to envi-
ronmental stresses imposed in vitro, during macrophage infec-
tion, and in human disease (reviewed in ref. 3–5).
In this article, we will review emerging information on the 
presence of non-coding RNA in M. tuberculosis and consider its 
potential contribution to the adaptive responses that underlie dis-
ease pathogenesis and persistence.
Different Types of Non-coding RNA in Bacteria
Application of high-density tiling arrays and RNA sequencing 
technologies (RNA-seq) have uncovered an extensive and pre-
viously unknown repertoire of non-coding RNA in bacteria, 
including 5' and 3' untranslated regions (UTRs), antisense tran-
scripts and intergenic small RNAs (sRNAs).6,7 This is also the 
case in M. tuberculosis.8
The 5' UTR, refers to the region between the transcriptional 
and the translational start sites. This part of the transcript can 
in some cases change its conformation in response to external 
stimuli such as changes in temperature9 or the availability of cer-
tain metabolites, in which case the RNA element is referred to 
as a riboswitch.10 The change in conformation in turn leads to a 
change in the expression of the downstream gene either by block-
ing/unblocking of the ribosome binding site or by transcriptional 
termination/antitermination.11 An intriguing finding is that 
the riboswitch moiety of the SAM-IV riboswitch from Listeria 
monocytogenes can act in trans as an sRNA thereby adding fur-
ther complexity to the regulation by riboswitches.12 Whether this 
applies to other riboswitches or perhaps attenuated transcripts in 
general remains to be determined.
sRNAs are, as the name indicates small transcripts, mostly 
in the range of 50 to 250 nucleotides, and they can be encoded 
opposite open reading frames (antisense or cis-encoded) or 
between open reading frames (intergenic or trans-encoded).
The majority of sRNAs regulate gene expression by base-pair-
ing to one or more target mRNAs thereby modifying translation 
efficiency and/or mRNA stability.13,14 One widespread exception 
is 6S RNA, which binds to RNA polymerase thereby specifically 
downregulating the usage of σ70 promoters.15 Other examples of 
protein binding sRNAs include CsrB and CsrC, which both bind © 2012 Landes Bioscience.
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chaperones30 will hopefully shed more light on these questions 
in near future.
sRNAs and Pathogenesis
While functional characterization of intergenic sRNAs has only 
recently been initiated in M. tuberculosis, numerous sRNAs have 
been characterized in other pathogens. Many of these sRNAs 
are induced by stress and hence associated with host adaptation 
and virulence.6,21,31 In some cases sRNAs enhance their effect by 
regulating regulators such as the Qrr1–4 sRNAs, which regulate 
HapR in Vibrio cholera,32 or ArcZ, which regulates the expres-
sion of RpoS in both E. coli and Salmonella.33,34 Other sRNAs 
that are intimately related to pathogenesis and survival within 
the host are RybB and MicA, which upon acid stress promote the 
degradation of several outer membrane protein (OMP) mRNAs 
in Salmonella. This leads to a rapid rearrangement of the outer 
membrane, and hence the host-pathogen interface until a new 
homeostasis has been achieved.35 In spite of the close relation-
ship between stress, host adaptation and pathogenesis, only a 
fraction of sRNAs has been shown to directly affect virulence in 
different infection models.21 These include the S. aureus Sprd,36 
L. monocytogenes Rli38,37 Legionella pneumophilia ssrS (encoding 
6S RNA),38 and the three Salmonella sRNAs IsrM,39 IstR and 
SroA;40 all of these sRNAs result in impaired virulence upon dele-
tion. Deletion of L. monocytogenes RliB and V. cholerae VrrA lead 
to increased colonization of spleen and intestines, respectively.37,41
Coding vs. Non-coding RNA in M. tuberculosis
The identification of putative regulatory sRNAs in M. tubercu-
losis is so far limited to three studies.8,29,42 Figure 1 presents an 
overview of some of the putative RNA-based regulatory networks 
in M. tuberculosis.
The most recent study is a detailed quantitative analysis of 
M. tuberculosis transcriptomes from exponential and stationary 
phases using RNA-seq.8 After removal of signals from rRNAs, 
17% of the reads identified from exponentially growing M. tuber-
culosis H37Rv mapped to intergenic regions, with a further 12% 
mapping in antisense orientation to coding sequences. Non-
coding RNA increased to 58% of total (non-rRNA) reads in sta-
tionary phase cultures, largely due to accumulation of a single, 
highly abundant sRNA transcript, MTS2823 (see below). It is 
likely that these numbers represent an underestimate of the total 
non-coding transcriptome, since the protocol used in this study 
was not optimised for detection of shorter transcripts (<200 
nucleotides), which was reflected by the relatively low ratio of 5S 
to the larger 16S and 23S rRNA species.8
Not all intergenic transcripts will be non-coding and the dis-
tinction between coding and non-coding transcripts is contingent 
on the methods employed to predict protein-coding transcripts; 
the outcome varies according to different algorithms that have 
been used to generate multiple annotations of M. tuberculosis 
genomes. Identical short open reading frames are more frequently 
annotated as coding sequences in M. tuberculosis CDC1551 43,44 
than in the closely related M. tuberculosis H37Rv.2 For example, 
to the carbon storage regulatory protein, CsrA (reviewed in ref. 
16).
Although sRNAs are generally referred to as regulatory and/
or non-coding RNAs, a few have been found to encode small 
peptides as well as acting on RNA level.17 Other small intergenic 
transcripts appear to be acting purely as templates for the synthe-
sis of small peptides.18,19
The RNA Chaperone Hfq
In Gram negative bacteria, including many pathogens the RNA 
chaperone Hfq is required to facilitate the interaction between 
trans-encoded sRNAs and their targets.
Deletion of the hfq gene often leads to loss of virulence, which 
may in part be due to loss of proper sRNA function.20,21 However, 
the role of Hfq in the Gram positive Staphylococcus aureus is more 
controversial,22,23 and the protein is completely absent in several 
pathogens including M. tuberculosis.20 This lack of Hfq represents 
a limitation in extrapolation of experimental approaches as well 
as sRNA mechanisms from other bacterial systems both in terms 
of sRNA-mRNA interaction, but also in terms of the subsequent 
fate of transcripts via engagement with the degradosome, which 
is mediated by Hfq.24
The obvious question is, whether M. tuberculosis sRNAs can 
and do interact with their targets unaided or whether in M. 
tuberculosis there is one or more alternative, hitherto unidentified 
chaperones. The high GC content (67%) as well as the struc-
ture of intrinsic terminators in M. tuberculosis (see below), limits 
the frequency of AU-rich stretches implicated in conventional 
Hfq interactions.25 Nevertheless, an alternative chaperone could 
be considered an appropriate Hfq analog if it were to display a 
broad, albeit different sequence specificity toward the majority 
of sRNAs and their targets. One candidate for this type of chap-
erone is Rv2367. This protein is a homolog of the Sinorhizobium 
meliloti YbeY protein that has been shown to display certain Hfq 
functions,26 although the low level expression of Rv2367 con-
trasts with the abundance of Hfq in Escherichia coli.8,27
Alternatively (or in parallel) one could imagine a range of 
regulon-specific chaperones, each of which could interact with 
a subset of sRNAs and their targets in a manner similar to the 
FbpABC proteins in Bacillus subtilis.28 Finally there is the pos-
sibility that sRNA function in M. tuberculosis is independent 
of chaperones. But what are the pros and cons of riboregula-
tion without RNA chaperones? On one hand the nucleotide 
composition of M. tuberculosis sRNAs will in all likelihood lead 
to structures that have a significantly higher degree of intra-
molecular stability, which are more difficult to disrupt and 
these would therefore impair the interaction with target RNAs. 
On the other hand it is also possible that a higher proportion 
of G and C nucleotides in the seed sequence will facilitate the 
interaction between sRNA and target. Supporting this notion is 
the fact that some M. tuberculosis sRNAs are predicted to har-
bour unpaired C-rich stretches that would make for strong first 
interactions.29
Future investigations, in which tagged sRNAs are used as bait 
for the isolation of RNA-binding proteins and hence putative © 2012 Landes Bioscience.
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the 3' UTR of Rv0795c generates an antisense transcript that 
extends over the 3' end of the converging phoR8 (Arnvig KB, TC, 
Young DB unpublished). Similarly, the ino1 gene (Rv0046c) is 
covered by a mid-ORF antisense transcript, which is significantly 
downregulated between exponential and stationary phase growth8 
(Fig. 2). ino1 encodes an enzyme that catalyzes the first step in 
inositol  synthesis 
transcription of the sequence annotated as an intergenic region 
between Rv2395 and Rv2396 in H37Rv has been described as 
an sRNA (mcr7),42 but it is annotated as two hypothetical pro-
teins, MT2466 and MT2467 in the CDC1551 genome, and 
was recently reported to encode two small proteins involved in 
the mycobacterial response to low pH.45 Conversely, an abun-
dant transcript encoded between Rv3661 and Rv3662c has been 
alternatively annotated as sRNA MTS2823,8 and as hypotheti-
cal protein MT3762.44 In this case, the inverse orientation of the 
transcript with respect to the predicted protein strongly favors 
the sRNA annotation. Moreover, it is likely that some transcripts 
will have dual function as both sRNA and mRNA as it has been 
found in other bacteria.17 Initial predictions of translation start 
sites are also likely to be subject to revision in light of experi-
mental data, and this will result in reassignment of coding and 
non-coding portions of mRNA transcripts. Application of mass 
spectrometry technology for proteome analysis, e.g., reference 46 
and 47, will play an important role in resolving these ambiguities.
Antisense RNAs
Bacterial gene regulation by short antisense transcripts that base-
pair with 5' regions of mRNAs has been well characterized for a 
subset of bacterial genes, including several involved in transposi-
tion of foreign genetic elements.48 A surprising finding from sev-
eral studies using RNA-seq is the extent and heterologous nature 
of antisense transcriptomes. Thus, an antisense component has 
been identified for up to 75% of all protein-coding genes, with 
transcripts ranging in size from less than 50 nucleotides to several 
kilobases and mapping to sequences throughout the length of 
cognate mRNAs.49 A similar pattern is observed for M. tuberculo-
sis, where 65% of genes have an antisense component correspond-
ing to ≥10% of the coding transcript during exponential growth; 
a number that increases to >90% in stationary phase.8 Antisense 
transcripts have been shown to regulate transcription and transla-
tion of coding transcripts by a variety of mechanisms.48 Recently, 
RNase III-mediated digestion of double stranded sequences has 
been proposed as an attractive model by which antisense tran-
scription could play a pervasive genome-wide role in fine-tuning 
of expression patterns.49 During exponential growth in M. tuber-
culosis, all gene classes have some level of antisense RNA, but the 
gene classes with the lowest occurrence of antisense, are also the 
ones that are the most highly expressed, i.e., energy metabolism 
and synthesis of macromolecules.8
Several M. tuberculosis antisense transcripts have been identi-
fied by cloning and sequencing from low molecular weight RNA 
fractions or by RNA-seq, and their sizes as well as locations rela-
tive to their cognate open reading frames (ORFs) vary signifi-
cantly; some are encoded at the 5' end of the ORF, some in the 
center and some at the 3' end, and a few cover an entire ORF or 
more.8,29,42 Most of the M. tuberculosis antisense RNAs appear 
to be independent transcripts, but a few are derived from long, 
overlapping 3' UTRs (see below).8
PhoPR is a pathogenesis-associated two-component system 
that may be subject to riboregulation. There is a prominent inter-
nal antisense transcript toward the 5' end of the phoP gene, and 
Figure 1. Overview of the potential roles of regulatory RNA in M. tuber-
culosis. The figure illustrates how different external signals, shown as 
orange arrows, can regulate either riboswitches, antisense or intergenic 
RNAs (italics). Known protein regulators, i.e., DosR and SigF as well as 
selected sRNAs have been indicated with names. Blue lines indicate 
that the resulting regulation can be either activation or inhibition; full 
lines indicate known activation/inhibition; dashed arrows indicate pos-
sible consequence.
Figure 2. Expression of the ino1 antisense RNA is significantly downreg-
ulated in stationary phase. The figure illustrates RNA-seq data visualized 
with the Artemis genome browser; reads mapping to the plus strand, 
i.e., antisense to ino1, are shown in red, and reads mapping to the minus 
strand, i.e., ino1 itself, are shown in blue. Expression levels in the two 
phases have been adjusted for comparative reasons.© 2012 Landes Bioscience.
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by exploiting their resistance to digestion by 
Terminator 5'-phosphate-dependent exonu-
clease,56 3' ends are harder to define. A subset 
of M. tuberculosis mRNAs have well-defined 
3' ends associated with a recently identi-
fied mycobacterial terminator, TRIT,57 but 
the general paucity of L-shaped intrinsic 
terminators—i.e., a stem-loop followed by 
a stretch of U residues58—frustrates bioin-
formatics approaches to the prediction of 3' 
ends in M. tuberculosis. Visual inspection of 
RNA-seq profiles using a genome browser 
suggests that many mRNAs have 3' UTRs 
extending over more than 50 nucleotides. 
Long 3' UTRs stand out in the context of 
convergent gene pairs when they form a 
stretch of antisense transcript with potential 
base-pairing to the adjacent gene. The same 
phenomenon has been observed, albeit to a 
lesser extent, in e.g., L. monocytogenes.37 As 
in the case of the internal antisense transcripts discussed above, 
understanding of the functional consequence of overlapping 3' 
UTRs will require further experimental analysis, but it is intrigu-
ing that the set of genes subject to this form of antisense coverage 
shows a non-random distribution that is skewed toward genes 
with a shared role in cell wall processes.8 It will be interesting to 
explore whether the presence of a long 3' UTR has an influence 
on mRNA half-life and translation efficiency.
In contrast to 3' UTRs, which are more commonly associ-
ated with mRNA processing in eukaryotic cells, the role of 5' 
UTRs has been extensively characterized in bacteria. 5' UTRs 
typically provide binding sites for regulatory proteins or small 
molecules that modulate the efficiency of transcription or trans-
lation of the downstream sequence. A well-characterized exam-
ple is the inhibition of ribosomal protein expression by binding 
of free ribosomal protein to appropriate 5' UTRs, and release 
of inhibition when no free protein is available.59 Although no 
functional data are available, the presence of analogous 5' UTRs 
associated with corresponding genes in M. tuberculosis suggests 
that similar circuits play an important role in post-transcrip-
tional regulation.8
Riboswitches
A number of riboswitches have been identified in M. tuberculo-
sis by sequence homology;60 one of these, the cobalamin ribo-
switch has been subject to further investigation.61 This type 
of riboswitch represses the expression of the downstream gene 
in the presence of cobalamin (vitamin B12) and is often found 
upstream of genes involved in the synthesis and/or transport of 
cobalamin.62 There are two copies of this motif in M. tuberculo-
sis; one is upstream of the metE gene, encoding a B12-independent 
methionine synthase, and the second is upstream of an operon 
comprising PPE2, cobQ1 and cobU (Fig. 3). PPE2 belongs to 
an extensive family of proteins sharing proline-glutamate (PE) 
or proline-proline-glutamate (PPE) N-terminal motifs that were 
and this gene has been shown to be essential for virulence.50 
It is not unlikely that differential expression of either of these 
transcripts could affect the expression of their cognate mRNAs 
thereby playing a role in M. tuberculosis pathogenesis.
Two antisense RNAs associated with lipid metabolism have 
the interesting characteristic of the potential to base-pair with 
multiple mRNAs generated from duplicated gene sequences.29 
The first such antisense RNA, ASdes, maps to Rv0842c, encod-
ing an acyl-carrier protein desaturase (DesA1) and it has the 
potential for base-pairing with the mRNA of a second homolo-
gous target mRNA, DesA2 (Rv1094).29 The second example, 
ASpks, is encoded opposite of pks12 that encodes one of several 
polyketide synthases. These enzymes are required for biosyn-
thesis of a series of complex lipid molecules that are involved in 
pathogenesis,51-53 and act as targets for host immune recogni-
tion.54 ASpks is a 75-nucleotide transcript that maps to a dupli-
cated module in the 12.5 kb pks12 gene (Rv2048). Moreover, it 
has significant sequence identity with the equivalent modules 
in pks7, 8 and 15 and hence it could potentially base-pair with 
these mRNAs as well. During oxidative stress, and to a lesser 
extent at low pH, an extended 200-nucleotide ASpks transcript 
is induced.29 Oxidative stress also results in a downregulation of 
pks12, pks8 and pks15 mRNAs;5 further analysis should clarify if 
this is due to the increased ASpks levels.
Thus, the extent of the antisense transcriptome suggests that 
it may represent a common component of gene regulation in M. 
tuberculosis, with the potential in some cases for cis-regulation of 
their cognate mRNA partner as well as coordinated trans-regu-
lation of related genes.
3' and 5' Untranslated Regions (UTRs)
Sequences flanking either end of mRNA transcripts make an 
important contribution to the total complement of non-coding 
RNA. While it is relatively straightforward to identify the pri-
mary 5' ends of transcripts by RLM-RACE,55 or more globally 
Figure 3. M. tuberculosis riboswitches and PE-PPE genes; the figure illustrates how riboswitches 
in M. tuberculosis are sometimes separated from their predicted cognate mRNAs (shown 
in blue), by the insertion of one or more PE-PPE genes (shown in red). Due to the sequence 
conservation inherent in these riboswitches, the regions have been annotated as ‘conserved 
hypotheticals’ (shown in green). Other genes are shown in gray. The top part shows how the B12 
riboswitch is separated from cobQ1 and cobU genes by a PPE2 insertion. The bottom part shows 
how the Mbox has been separated from mgtC by several PE-PPE genes.© 2012 Landes Bioscience.
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level of transcription initiation by iron and zinc.70 In addition 
to its transcriptional attenuation profile the 5' UTR contains a 
highly conserved region, which could constitute a ligand-bind-
ing aptamer domain. It is intriguing to note that once again 
this putative riboswitch is located upstream of an operon con-
taining a PE-PPE gene pair, extending a pattern of PE-PPE gene 
insertion between riboswitches and their predicted regulated 
targets. A YdaO riboswitch (candidate) is present upstream of 
rpfA (Rv0867c) in M. tuberculosis. No ligand has been identified 
for the YdaO riboswitch though it is often associated with genes 
involved in processes related to cell wall degradation.71 The rpfA 
gene product is a member of a family of “resuscitation-promoting 
factors” that share structural homology with lysozyme, and may 
play a particularly important role in re-initiation of cell division 
after periods of non-replication.72-74
These examples suggest that riboswitches have a widespread 
role in regulation of M. tuberculosis gene expression and growth.
M. tuberculosis Intergenic sRNAs and Stress
Around 20 M. tuberculosis intergenic sRNAs have been identi-
fied and verified by northern blotting.8,29,42 They display vary-
ing degrees of conservation; some are restricted to closely related 
members of the M. tuberculosis complex, others are present in 
multiple pathogenic mycobacteria with Mycobacterium leprae 
being the most distant relative, and finally some are conserved 
in all mycobacteria and even other actinomycetes.8,29,42 The M. 
tuberculosis sRNAs range in size from ~50 to >300 nucleotides, 
they are often differentially expressed in response to changing 
environments, and a couple have been shown to be lethal upon 
overexpression. Selected examples are listed in Table 1 using 
an MTS (“Mycobacterium tuberculosis sRNA”) designation fol-
lowed by a number corresponding to the intergenic region i.e., 
the TIGR website annotation of intergenic regions (cmr.jcvi.org/
tigr-scripts/CMR/CmrHomePage.cgi).
The differential expression of sRNAs upon changing growth 
conditions may give some clues about function in terms of under 
identified from the M. tuberculosis genome sequence but for the 
most part lack any obvious biological function.63 The genomic 
location of PPE2, together with the presence of several trans-
membrane domains has led to the suggestion that it may be a 
cobalt transporter.62 The cobalamin riboswitches in M. tubercu-
losis are predicted to act on the level of translation by masking/
unmasking the ribosome-binding site;64 on the other hand, a 
B12-dependent reduction in metE RNA has been interpreted as 
regulation on the level on transcription.61 This apparent conflict 
is possibly due to a destabilization of the metE transcript in the 
absence of translation.
Another riboswitch motif that is represented twice in the 
genome of M. tuberculosis but which has not been function-
ally characterized, is the ykok leader or Mbox, which is usually 
found in the context of magnesium transporters.65 The Bacillus 
subtilis Mbox has been shown to attenuate transcription upon 
binding Mg2+, thereby ensuring magnesium homeostasis.66 In 
M. tuberculosis one highly expressed Mbox is found upstream 
of Rv1535, a conserved hypothetical protein that is induced dur-
ing Mg-starvation.8,67 Rv1535 is followed by and co-transcribed 
with a downstream Tbox (a riboswitch that binds tRNAs68) that 
forms the 5' UTR of the essential isoleucine tRNA synthase 
mRNA (IleS, Rv1536),8 (Arnvig KB, Young DB unpublished). 
The second Mbox is located upstream of a putative operon 
encoding four PE-PPE genes, a conserved hypothetical protein 
and a predicted magnesium transporter, MgtC (Fig. 3), all of 
which are induced by magnesium starvation.67 The fact that 
the genes downstream of the two Mboxes in M. tuberculosis are 
induced upon magnesium starvation, strongly suggest that these 
are in fact functional magnesium-responsive RNA elements, 
which are activated by the low concentration of magnesium 
found in macrophages.69
Inspection of M. tuberculosis RNA-seq profiles identifies 
numerous additional candidate riboswitches expressed as trun-
cated 5' transcripts8 (Arnvig KB, Young DB unpublished). One 
of these is located in the 5' UTR of Rv0282, the first gene in the 
ESX3 operon that is essential for virulence and regulated at the 
Table 1. Selected intergenic sRNAs, verified by northern blotting
sRNA Alternative name Strand Left CDS Right CDS Size* Regulation** Ref.
MTS0194 F6 F Rv0243 Rv0244c 55, 110 SigF, starvation, H2O2, low pH 29
MTS0479 B55 F Rv0609A Rv0610c 60 H2O2 29
MTS0823 mpr5 F Rv1051c Rv1052 120 - 42
MTS0858 R Rv1092c Rv1093 100 - 8
MTS0997 mcr11 R Rv1264 Rv1265 120 CRP, stationary phase, infection 8, 42
MTS1082 F Rv1373 Rv1375 130 - 8
MTS1310 G2 R Rv1689 Rv1690 65 Exponential phase 29
MTS1338 F Rv1733c Rv1734c 120 DosR, hypoxia, infection 8
MTS2774 mpr17 F Rv3596c RV3597c 80, 110 - 42
MTS2822 B11 R Rv3660c Rv3661 95 H2O2 28
MTS2823 mpr4 F Rv3661 Rv3662c 305 stationary phase, infection, low pH 8, 42
MTS2975 F Rv3843c Rv3844 100 Exponential phase 8
Notes: *Approximate size (nucleotides) of the dominant transcripts as determined by northern blotting; **Regulation refers to relevant factors and 
conditions where increased expression is observed.© 2012 Landes Bioscience.
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required for remodelling of protein, lipid and energy metabolism 
together with members of the universal stress protein family and 
multiple proteins of unknown function.5 The DosR genes are 
strongly expressed during infection in mice and in sputum sam-
ples from patients, and include several prominent antigens, and 
their expression has been linked to the generation of drug toler-
ant persister cells.3,80,81 It remains to be determined if MTS1338 
is directly involved in the generation of persister cells or simply a 
marker for this subpopulation.
The most in-depth functional analysis has been performed on 
the relatively large (~300-nucleotide) MTS2823 sRNA, which is 
encoded on the plus strand between Rv3661 and Rv3662c. It is 
the most highly expressed non-rRNA in exponentially growing 
cultures, is induced a further 10-fold in stationary phase, and 
accumulates to a level approaching 1:1 stoichiometry with rRNA 
in tissues from infected mice.8 MTS2823 is conserved in a broad 
range of mycobacteria (and other actinomycetes).
Constitutive overexpression of MTS2823 in exponential 
phase cultures results in a slightly reduced growth rate and in a 
widespread downregulation of energy metabolism genes, analo-
gous to that observed during transition from exponential growth 
to stationary phase.8 The most marked reduction is seen for 
genes associated with the methyl citrate cycle in particular prpC 
(methyl citrate synthase, >100 fold) and prpD (methyl citrate 
dehydratase, >60 fold). This metabolic pathway contributes to 
detoxification of metabolites generated during catabolism of odd-
numbered fatty acids and cholesterol, which has been shown to 
be an essential carbon source during intracellular growth.82,83
Downregulation of active growth functions during station-
ary phase transition in bacterial cultures is commonly associated 
with increased expression of the structurally conserved 6S RNA 
molecule, that binds to RNA polymerase and inhibits transcrip-
tion of genes controlled by the principal sigma factor.15,84,85 A 
bioinformatics search based on matching for energetically sub-
optimal structures recently identified the M. smegmatis homo-
log of MTS2823 as a potential 6S RNA candidate, but lack of 
binding to RNA polymerase led the authors to conclude that it 
is not a genuine 6S RNA,86 and so far no 6S RNA homolog has 
been identified in mycobacteria. It remains to be determined if 
MTS2823 is a conventional sRNA that acts via base-pairing with 
specific mRNA targets or with protein or whether its mode of 
action differs entirely from other sRNAs.
M. tuberculosis sRNA Networks?
Generally, the roles of individual sRNAs within a cell’s regula-
tory networks vary substantially. Well-characterized sRNAs can 
be, and in the case of Salmonella and E. coli have been, assigned 
to different types of regulatory circuits depending on the inter-
play between regulators, sRNAs and targets.87 However, in the 
case of M. tuberculosis this requires a significant increase in the 
amount of data about individual sRNAs that we are only just 
beginning to collect. Once the different regulators and targets of 
M. tuberculosis sRNA have been identified, monitoring the fate 
of target mRNAs upon deletion or overexpression of sRNAs will 
help to distinguish between different mechanistic models.
what conditions a given sRNA may be required, although it will 
not reveal the entire story.
MTS194, MTS479 and MTS2822. Oxidative stress is a 
potent inducer of stress responses in M. tuberculosis.75 Three of 
the sRNAs listed in Table 1, namely MTS194 (“F6”29), MTS479 
(“B55”29) and MTS2822 (“B11”29) show increased expression in 
response to H2O2, which mimics the oxidative stress encountered 
inside the host macrophage, and hence these sRNAs could be 
associated with intracellular survival during the early stages of 
infection. MTS194 is encoded in the intergenic region between 
two genes involved in lipid degradation, Rv0243 and Rv0244c. 
It is transcribed by the starvation associated alternative sigma 
factor, SigF and the MTS194 promoter has recently been shown 
to represent the highest occupancy of this sigma factor suggest-
ing that expression of this sRNA has high priority under certain 
conditions such as starvation.76 Overexpression of MTS194 leads 
to reduced growth in M. tuberculosis, but although an MTS194 
homolog is present in the distantly related, non-pathogenic 
Mycobaterium smegmatis, overexpression of MTS194 in M. smeg-
matis has no obvious phenotype.29
MTS2822. MTS2822 is ~95 nucleotides in size and located 
in the intergenic region between Rv3660c and Rv3661, both pre-
dicted to be involved in cellular differentiation. Downstream of 
Rv3661 is another sRNA, MTS2823 (see below), and the entire 
locus is highly conserved among mycobacteria, with the notable 
exception of M. leprae. MTS2822 contains a so-called 6C motif, 
consisting of two C rich loops found to be widespread between 
Actinobacteria.77 The structure of MTS2822 has led to the sug-
gestion that this sRNA may be a structural/protein binding RNA 
rather than a conventional regulatory sRNA.77 M. smegmatis har-
bours an sRNA that is >90% identical to MTS2822 and while 
overexpression of MTS2822 in M. tuberculosis is lethal, overex-
pression of MTS2822 in M. smegmatis results in a dramatic phe-
notype; growth is very poor on solid and in liquid media, and 
the cells display aberrant morphology including irregular and 
elongated shape, suggesting association with cell wall synthesis 
and/or cell division.29
MTS997, MTS1338 and MTS2823. Three other sRNAs, 
MTS997, MTS1338 and MTS2823 accumulate to high levels 
during the transition from exponential to stationary phase, (rep-
resenting a mixture of stresses), and to even higher levels dur-
ing infection, suggesting a role in pathogenesis.8,42 MTS997 and 
MTS2823 are both expressed during exponential growth while 
MTS1338 is almost undetectable under the same conditions. 
The number of MTS1338 molecules, relative to the number of 
ribosomes, estimated to be around 4,000 per cell during fast 
growth,78 imply that less than 10% of exponentially growing 
cells express MTS1338. It therefore seems plausible that the few 
cells expressing this sRNA may be in a different metabolic state 
than the remaining population and therefore they could repre-
sent putative persister cells. Moreover, the induction of MTS1338 
seen in stationary phase is almost eliminated by deletion of dor-
mancy regulator, DosR.8 DosR interacts with DosS or DosT 
to form a phosphorylation-dependent two-component regula-
tory system activated during growth arrest induced by hypoxia 
or exposure to nitric oxide.79 The DosR regulon includes genes © 2012 Landes Bioscience.
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tractable organisms and to focus experimental work with M. 
tuberculosis on aspects of particular relevance to pathogenesis.
It can be envisaged that research on non-coding RNA in M. 
tuberculosis will contribute in three areas: improved understand-
ing of the regulation of pathways already implicated in patho-
genesis, characterization of M. tuberculosis phenotypes relevant to 
human infection, and hence, although more long-term, improved 
interventions for disease control.
Improved understanding. Over more than a decade since the 
sequencing of the M. tuberculosis genome, research in many labo-
ratories has focused on identification of protein encoding genes 
and regulons implicated in pathogenesis; typically by generation 
of recombinant strains and subsequent testing of their pheno-
type in a mouse model of infection. Analysis by genome-wide 
transposon mutagenesis identified almost 200 protein encoding 
genes that are dispensable for growth in laboratory culture but 
are required for infection,52,53 and individual studies have charac-
terized multiple genetic loci involved in control of defense against 
host antimicrobial systems, adaptation to changing nutritional 
and physicochemical constraints, and production of macromol-
ecules that modulate interactions with host cells. RNA-seq pro-
filing identifies non-coding RNA elements associated with many 
of these loci.8
Characterization of M. tuberculosis phenotypes. While 
mouse infection provides a convenient model to analyze M. 
tuberculosis growth dynamics in the presence of host innate and 
adaptive immune cells, it does not recapitulate the more complex 
biological processes underlying the disease transmission cycle. 
In humans and non-human primates, infection with M. tuber-
culosis induces formation of a heterogeneous and dynamic range 
of highly structured granulomatous lesions that provide a multi-
plicity of bacterial microenvironments.1 Successful pathogenesis 
involves an ability to tolerate the resulting unfavorable environ-
ments, and to exploit environments that are favorable for bacte-
rial multiplication, access to airways and onward transmission. It 
is likely that the mouse model interrogates only a portion of the 
phenotypic repertoire involved in human disease, and character-
ization of phenotypic states relevant to different stages of human 
pathology presents a major research challenge. Accumulation of 
sRNAs linked to different stress regulons may act as sensitive 
markers of the physiological status of the small numbers of bac-
teria present in different parts of human and non-human lesions, 
providing crucial information to support rational targeting of 
improved therapies.1
Improved interventions. The success of treatment-based 
strategies for tuberculosis control is limited by the requirement 
for therapeutic regimens extending over 6 mo or more. Prolonged 
treatment is needed to clear a residual population of bacteria that 
persist in a phenotypic condition in which they are tolerant to 
antibacterial drugs. Identification of drugs that have a cidal effect 
against persister populations is a key research goal. Phenotypic 
tolerance can be reproduced in vitro by driving bacteria into a 
non-replicating state by limitation of oxygen or nutrients. In 
vitro “persister” models share the characteristic of a widespread 
downregulation of genes required for active growth,96-98 and it is 
likely that MTS2823 makes a contribution to this process. An 
CRISPR
The Clustered Regularly Interspaced Short Palindromic Repeat 
(CRISPR) locus provides a specialized source for generation 
of  M. tuberculosis sRNAs. The CRISPR locus incorporates 
sequences from phage and other invading genetic elements and 
repackages them as sRNA defense molecules that confer resis-
tance to re-infection.88 CRISPRs are found in only a subset of 
mycobacteria, and the presence of the CRISPR in Mycobacterium 
canetti suggests acquisition by horizontal transfer prior to final 
branching of the M. tuberculosis complex. Sporadic deletion of 
integrated foreign sequence elements from the CRISPR domain 
has been exploited in a widely used system for differentia-
tion of M. tuberculosis strains referred to as “spoligotyping.”89 
Phylogenetically, the M. tuberculosis CRISPR system belongs to 
the Type III-A family,90 and is related to a well-characterized 
CRISPR system in Staphylococcus epidermis.91 The Type III-A 
system is characterized by the presence of Cas10 (Rv2823c) 
and Csm6 (Rv2818) in the CRISPR Associated Complex for 
Antiviral Defense (CASCADE), which in M. tuberculosis is 
likely to target foreign DNA rather than RNA.90 Inspection of 
RNA-seq profiles shows that the CRISPR domain is transcribed 
and processed into a series of 50–60 nucleotide sRNAs that are 
presumably incorporated into a CASCADE effector complex 
(Arnvig KB, TC, Young DB unpublished). The transcription 
start site driving CRISPR sRNA expression overlaps with a 
divergent start site that generates a long antisense transcript cov-
ering Rv2816c and Rv2817c encoding Cas1 and Cas2 proteins 
involved in incorporation of novel sequences into the CRISPR 
locus8,92 (Arnvig KB, TC, Young DB unpublished). This profile 
is consistent with silencing of the genes required to capture novel 
CRISPR sRNAs, but functional expression of Cas6 and Cas10 
enzymes (i.e., Rv2824c and Rv2823c) required for processing 
of pre-existing sRNAs. An exception is the sub-lineage of M. 
tuberculosis known as the Beijing family, which is undergoing 
a current global expansion in marked association with multiple 
drug resistance.93 A genomic deletion has removed most of the 
CRISPR locus and many of the associated Cas genes, eliminat-
ing expression of CRISPR sRNAs in these strains.94 A similar 
deletion has been found in an unrelated sub-lineage referred 
to as “pseudo-Beijing.”95 It is open to speculation whether the 
presence of a functional CRISPR system in the majority of M. 
tuberculosis strains has current biological relevance or reflects 
fortuitous retention of a defense system appropriate to an ances-
tral lifestyle.
Implications for Pathogenesis and Disease Control
Progression from documentation of the non-coding transcrip-
tome to elucidation of its biological function will require an exten-
sive program of experimental research. Given the limitations of 
working with a slow-growing pathogen under strict containment 
condition—the timeframe of biologically relevant experiments 
using M. tuberculosis routinely extends from 6 to 12 mo—it may 
be important to explore fundamental mechanisms using more © 2012 Landes Bioscience.
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role in the intracellular survival of this bacterium as it is the case 
for many other pathogens. Moreover, it is possible that riboregu-
lation may also be involved in the generation of persister cells 
that are phenotypically tolerant to conventional antibacterial 
drugs. Future investigations will hopefully shed more light on 
this aspect of M. tuberculosis biology.
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alternative to the environment-induced model is that the persister 
phenotype is generated spontaneously in a few individuals within 
an apparently homogeneous bacterial population as a result of 
stochastic variations in gene expression.99 Mathematical model-
ing suggests that post-transcriptional regulation could provide 
an important source of such stochastic variation,100 and measure-
ment of uninduced levels of an sRNA such as MTS1338 does 
indeed suggest occurrence at less than one copy per cell.
In summary the abundance of non-coding RNA in M. tuber-
culosis and its association with genes implicated in pathogenesis 
suggests that post-transcriptional regulation plays a significant 
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